Singapore grants Sinovac COVID-19 vaccine special access
The Peninsula
SINGAPORE: Singapore will allow usage of the coronavirus vaccine of China's Sinovac Biotech under its special access route, the city-state said on Wednesday, following its approval by the World Health Organization (WHO).
Singapore had this week said it would allow private healthcare providers to access COVID-19 vaccines not approved by Singapore but on the WHO's emergency use listing. Sinovac was added to the WHO list on Tuesday. The health ministry said it was studying the possibility for private healthcare institutions to access Singapore's current stock of 200,000 Sinovac doses, which it received in February.More Related News